Activism and Passivity

HSR Act and Section 13(d) developments for investors

ETER JONATHAN HALASZ, ELEAZER KLEIN, MICHAEL SWARTZ, ADRIANA SCHWARTZ, BEVERLY J. ANG AND CLARA ZYLBERG, SCHULTE ROTH & ZABEL LLP

On July 12, 2016, the US Department of Justice (the “DOJ”) announced that investment firm ValueAct had entered into a consent decree in which it agreed to pay $11 million to settle charges that two of its affiliated funds acquired large stakes in Halliburton Company (“Halliburton”) and Baker Hughes Incorporated (“Baker Hughes”) in violation of the notification and waiting requirements of the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the “HSR...

This article is only available to subscribers.

Having problems?

If you have any questions regarding subscriptions or restricted content, please contact us on +44 (0)207 278 3385 or info@hedgefundjournal.com